Cheminformatic Tools and Databases for Pharmacology

session 63929 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M QUETIAPINE (is an active metabolite)

QUETIAPINE


ATC N05AH04

NERVOUS SYSTEM
ANTIPSYCHOTIC
SCHIZOPHRENIA
DIBENZOTHIAZEPINE FAMILY
DOPAMINE D2 RECEPTOR ANTAGONIST (IC50=329 NANOMOLAR)
SEROTONIN (5HT2) ANTAGONIST (IC50=148 NANOMOLAR)
SEROTONIN 5HT1A ANTAGONIST (IC50=717 NANOMOLAR)
DOPAMINE D1 ANTAGONIST (IC50=1268 NANOMOLAR)
HISTAMINE H1 ANTAGONIST (IC50=30 NANOMOLAR)
ADRENERGIC ALPHA 1 RECEPTOR ANTAGONIST (IC50= 94 NANOMOLAR)
ADRENARGIC ALPHA 2 RECEPTOR ANTAGONIST (IC50=271 NANOMOLAR)
NO APPRECIABLE AFFINITY AT CHOLINERGIC MUSCARINIC AND BENZODIAZEPINE RECEPTORS (IC50 SUPERIOR TO 5000 NANOMOLAR)

- 5-HYDROXYTRYPTAMINE 2 RECEPTOR
D2 DOPAMINE RECEPTOR

D(2) dopamine receptor UNIPROT P14416 DRD2 -- 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
QUETIAPINE (has an active metabolite)

QUETIAPINE


ATC N05AH04

NERVOUS SYSTEM
ANTIPSYCHOTIC
SCHIZOPHRENIA
DIBENZOTHIAZEPINE FAMILY
DOPAMINE D2 RECEPTOR ANTAGONIST (IC50=329 NANOMOLAR)
SEROTONIN (5HT2) ANTAGONIST (IC50=148 NANOMOLAR)
SEROTONIN 5HT1A ANTAGONIST (IC50=717 NANOMOLAR)
DOPAMINE D1 ANTAGONIST (IC50=1268 NANOMOLAR)
HISTAMINE H1 ANTAGONIST (IC50=30 NANOMOLAR)
ADRENERGIC ALPHA 1 RECEPTOR ANTAGONIST (IC50= 94 NANOMOLAR)
ADRENARGIC ALPHA 2 RECEPTOR ANTAGONIST (IC50=271 NANOMOLAR)
NO APPRECIABLE AFFINITY AT CHOLINERGIC MUSCARINIC AND BENZODIAZEPINE RECEPTORS (IC50 SUPERIOR TO 5000 NANOMOLAR)

ORAL

F 100 PERCENT

VD 650 LITER (65 KILOGRAM)

PPB 83 PERCENT

Cl 75 LITER / HOUR (EQN)

HT 6 HOUR

SOLUBILITY MODERATELY SOLUBLE IN WATER

5-HYDROXYTRYPTAMINE 2 RECEPTOR
D2 DOPAMINE RECEPTOR

D(2) dopamine receptor UNIPROT P14416 DRD2 -- 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |